A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

4,005

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

June 30, 2014

Conditions
Smallpox
Interventions
BIOLOGICAL

IMVAMUNE®

0.5 ml IMVAMUNE® vaccine containing at least 1 x 10E8 TCID50 (standard dose)

OTHER

Placebo

0.5 ml TBS

Trial Locations (34)

14609

Rochester Clinical Research, Inc., Rochester

23507

Clinical Research Associates of Tidewater, Norfolk

25701

University Physicians Internal Medicine University Physicians & Surgeons, Inc., Huntington

27612

Wake Research Associates, Raleigh

29464

PMG Research of Charleston, Mt. Pleasant

31405

Southeast Regional Research Group, Savannah

32720

Avail Clinical Research, LLC, DeLand

32935

Accelovance Melbourne, Melbourne

33024

Broward Research Group, Hollywood

35294

Alabama Vaccine Research Clinic, Birmingham

37620

Holston Medical Group, Bristol

37920

Volunteer Research Group, Knoxville

44122

Rapid Medical Research, Inc., Cleveland

44691

Family Practice Center of Wooster, Wooster

61602

Accelovance Peoria, Peoria

63110

Washington University in St. Louis, School of Medicine, St Louis

65802

QPS Bio-Kinetic, Springfield

67010

Heartland Research Associates, Augusta

67207

Heartland Research Associates, LLC, Wichita

68134

Meridian Clinical Research, LLC, Omaha

70006

Benchmark Research, Metairie

73112

Lynn Health Science Institute, Oklahoma City

76135

Benchmark Research, Fort Worth

80907

Lynn Institute of the Rockies, Colorado Springs

83642

Advanced Clinical Research, Inc., Meridian

84041

Tanner Clinic, Layton

84088

Advanced Clinical Research, West Jordan

89104

Clinical Research Center of Nevada, LLC, Las Vegas

90057

National Research Institute, Los Angeles

92123

Therapeutics Clinical Research, San Diego

92801

Anaheim Clinical Trials, Anaheim

96001

Northern California Clinical Research Center (NCCRC), Redding

97239

Columbia Research Group, Inc., Portland

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bavarian Nordic

INDUSTRY